Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z-C Jing

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Heart (British Cardiac Society)|January 3, 2006
Different effects of tirofiban and aspirin plus clopidogrel on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusionY-J Yang, J-L Zhao, S-J You, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|July 25, 2017
[Establishment of a model of hydrogen peroxide-induced injury in pulmonary artery endothelium cells and relevant mechanisms of oxidative stress]J Ye, Y Y He, Y Yan, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|May 27, 2017
[Clinical efficacy and safety of thrombolytic treatment with reteplase in patients with intermediate-risk acute pulmonary embolism]H G Zhao, S X Wang, Z N Lu, et al.
BMC Cardiovascular Disorders|October 25, 2016
Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort studyY Huo, Z C Jing, X F Zeng, et al.
The European Respiratory Journal|June 22, 2010
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertensionM Humbert, O Sitbon, A Yaïci, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Heart (British Cardiac Society)|January 3, 2006
Different effects of tirofiban and aspirin plus clopidogrel on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusionY-J Yang, J-L Zhao, S-J You, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|July 25, 2017
[Establishment of a model of hydrogen peroxide-induced injury in pulmonary artery endothelium cells and relevant mechanisms of oxidative stress]J Ye, Y Y He, Y Yan, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|May 27, 2017
[Clinical efficacy and safety of thrombolytic treatment with reteplase in patients with intermediate-risk acute pulmonary embolism]H G Zhao, S X Wang, Z N Lu, et al.
BMC Cardiovascular Disorders|October 25, 2016
Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort studyY Huo, Z C Jing, X F Zeng, et al.
The European Respiratory Journal|June 22, 2010
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertensionM Humbert, O Sitbon, A Yaïci, et al.
Pageof 2